Statistics for Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
Total visits
| views | |
|---|---|
| Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group | 388 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| Ann Oncol 441.pdf(legacy) | 514 |
| Ann Oncol 441.pdf | 7 |
Top country views
| views | |
|---|---|
| United States | 184 |
| China | 42 |
| United Kingdom | 27 |
| Germany | 14 |
| France | 14 |
| Russia | 14 |
| Portugal | 12 |
| Poland | 10 |
| Italy | 9 |
| Australia | 7 |
| Netherlands | 6 |
| Brazil | 5 |
| India | 4 |
| Turkey | 4 |
| Argentina | 3 |
| Canada | 3 |
| Mongolia | 3 |
| Ukraine | 3 |
| Spain | 2 |
| United Arab Emirates | 1 |
| Colombia | 1 |
| Czechia | 1 |
| Denmark | 1 |
| Egypt | 1 |
| Hong Kong SAR China | 1 |
| Iran | 1 |
| Japan | 1 |
| Morocco | 1 |
| Peru | 1 |
| Singapore | 1 |
| Vietnam | 1 |